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In patients with pulmonary hypertension due to pulmonary vascular disease postoperative mortality is appreciably increased. Episodes of acute reactive pulmonary hypertension have been reported after surgical correction of several congenital cardiac abnormalities.' 2 To prevent a fatal outcome of these episodes prompt treatment with vasodilating drugs and hyperventilation with pure oxygen is mandatory. 3 Numerous pulmonary vasodilators have been described, but the pulmonary response to all these drugs is unpredictable. Laboratory studies have shown glyceryl trinitrate to be an effective pulmonary vasodilator.4 It also lowers patients' pulmonary artery pressures considerably.56 To our knowledge glyceryl trinitrate has not previously been used to treat a pulmonary hypertensive crisis in a child after cardiac surgery. We report the successful use of the drug in a case of reactive pulmonary hypertension after a switch operation for transposition of the great arteries. None of the above known stimuli was present in our patient. Detachment of the ventricular septal defect patch was a consideration but could be ruled out as there was no appreciable increase in the oxygen saturation between the right atrium and the pulmonary artery. Administration of one litre of blood could have led to the development of pulmonary hypertension by infusion of microaggregates, but the blood was less than 12 hours old and therefore unlikely to have formed microaggregates.'7 Extensive laboratory investigations also failed to show any sign of intravascular clotting.
Hyperventilation with pure oxygen, fentanyl, and isoprenaline failed to change the pulmonary artery pressure. Prostaglandin El dilates the pulmonary as well as the systemic vessels. The effect on the pulmonary circulation is unpredictable,'8 '9 and our patient did not respond to a relatively high dosage of 1 ,ug/kg infused directly into the pulmonary artery. Tolazoline has successfully been used in the treatment of pulmonary vasoconstriction,' 2 20 but because we had previously noted an equal fall in the systemic and pulmonary arterial pressures tolazoline was not used.
Sodium nitroprusside and glyceryl trinitrate relax the musculature of both the systemic and pulmonary vessels. At normal dosages glyceryl trinitrate mainly effects the venous system without lowering the systemic arterial pressure unduly.56 The action of sodium nitroprusside on the pulmonary vessels normally becomes effective only after considerable changes in systemic resistance and pressure2' 22; its successful use has, however, been reported in a patient who could not be weaned off cardiopulmonary bypass because of pulmonary hypertension. '6 Methaemoglobinaemia can be a complication of treatment with intravenous glyceryl trinitrate. At infusion rates of less than 7 ,ug/kg/min the methaemoglobin concentration, normally less than 1 g/dl, does not exceed 2 g/dl.23 The maximum dosage used in our patient was 12 ,ug/kg/min, at which rates it may be advisable to monitor methaemoglobin concentrations. The extent to which the ratio between the pulmonary and systemic arterial pressures should be lowered postoperatively is not known. In a retrospective study of ventricular septal defects it appeared that Reactive pulmonary hypertension after a switch operation a preoperative ratio of <0-45 was associated with the lowest postoperative mortality.24 Increases in the pulmonary arterial pressure >60%/6 of the systemic arterial pressure have been reported to be dangerous and should be lowered if possible. 25 Treatment of reactive pulmonary hypertension must be prompt to prevent acute dilatation and failure of the right ventricle.' Glyceryl trinitrate has been found to be an effective pulmonary vasodilator, and we think that its use should probably be recommended in preference to other more generally used drugs because a minimal and predictable effect on the systemic pressure is achieved while cardiac output is increased.
